The company’s product for continuous lung monitoring of preterm born infants is attracting significant international interest.
Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial medical need, and what remains to be done before submitting a regulatory application to the FDA.